Audrey Mauguen, PhD

Associate Attending Biostatistician

Audrey Mauguen, PhD

Associate Attending Biostatistician


ISPED, University of Bordeaux (France)

Current Research Interests

Dr. Mauguen’s methodological research focuses on survival analyses and the prediction of survival endpoints. She is particularly interested in using information from complex covariates such as recurrent events and biomarker evolution. She also worked on improving the diagnostic and prediction of cancer risk by proposing a strategy to define cancer subtypes. Finally, she is working on improving clinical trial design for rare diseases. She is collaborating with clinical investigators from the Department of Pediatrics and the Molecular Imaging and Therapy Service.


R package frailtypack: General Frailty Models: Shared, Joint and Nested Frailty Models with Prediction (first author: Virginie Rondeau)

R package Clonality: Testing for clonal relatedness versus independence of tumors from the same patient (first author: Irina Ostrovnaya)


Selected peer-reviewed publications:

  1. Mauguen A. Accounting for the rarity of the disease when designing clinical trials with a focus on pediatric cancers. Clinical Trials. March 2022. doi:10.1177/17407745221080728 [epub ahead of print]
  2. Mauguen A, Seshan VE, Ostrovnaya I, Begg CB. An EM algorithm to improve the estimation of the probability of clonal relatedness of pairs of tumors in cancer patients. BMC Bioinformatics. 2019 Nov 8;20(1):555. doi: 10.1186/s12859-019-3148-z.
  3. Mauguen A, Seshan VE, Ostrovnaya I, Begg CB. Estimating the probability of clonal relatedness of pairs of tumors in cancer patients. Biometrics. 2018 Mar;74(1):321-330. doi: 10.1111/biom.12710.
  4. Mauguen A, Zabor EC, Thomas NE, Berwick M, Seshan VE, Begg CB. Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma. J Am Stat Assoc. 2017;112(517):54-63. doi: 10.1080/01621459.2016.1191499.
  5. Mauguen A, Rachet B, Mathoulin-Pélissier S, MacGrogan G, Laurent A, Rondeau V. Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models. Stat Med. 2013 Dec 30;32(30):5366-80. doi: 10.1002/sim.5980.

View a full listing of Audrey Mauguen’s journal articles.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Audrey Mauguen discloses the following relationships and financial interests:

No disclosures meeting criteria for time period

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures